跳至主要内容
临床试验/NL-OMON40369
NL-OMON40369已完成3 期

The effect of fish oil supplements during supervised exercise therapy in patients with intermittent claudication - FISHTIC-study

Medisch Centrum Alkmaar0 个研究点目标入组 136 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
136

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • *Age * 18
  • *Newly diagnosed intermittent claudication
  • *Ankle Brachial Index < 0.8 at rest or > 0.15 decrease after exercise
  • *Able to perform standardized treadmill walking test for 2 min
  • *Written informed consent

排除标准

  • *Unable to fill out a questionnaire (cognitive impairment or insufficient knowledge of the Dutch language)
  • *Heart failure or unstable cardiac status (angina pectoris NYHA class III or IV or recent myocardial infarction < 3 months)
  • *Any illness with rapid evolution or a life expectancy < 3 months
  • *Recent cerebrovascular accident (< 3 months)
  • *Current use of fish oil supplements or > 2 times a week dietary fish
  • *Pregnancy
  • *Fish, soybean or peanut allergy
  • *Contra indications for the use of omega-3 fatty acids
  • - Use of oral anti-coagulants (coumarin derivatives)

研究者

发起方
Medisch Centrum Alkmaar

相似试验